Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France

Leticia Quintanilla-Martinez, Daphne de Jong, Antoine de Mascarel, Eric D Hsi, Philip Kluin, Yaso Natkunam, Marie Parrens, Stefano Pileri, German Ott

Research output: Contribution to journalArticleAcademicpeer-review

63 Citations (Scopus)

Abstract

The term "gray-zone" lymphoma has been used to denote a group of lymphomas with overlapping histological, biological, and clinical features between various types of lymphomas. It has been used in the context of Hodgkin lymphomas (HL) and non-Hodgkin lymphomas (NHL), including classical HL (CHL), and primary mediastinal large B cell lymphoma, cases with overlapping features between nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B cell lymphoma, CHL, and Epstein-Barr-virus-positive lymphoproliferative disorders, and peripheral T cell lymphomas simulating CHL. A second group of gray-zone lymphomas includes B cell NHL with intermediate features between diffuse large B cell lymphoma and classical Burkitt lymphoma. In order to review controversial issues in gray-zone lymphomas, a joint Workshop of the European Association for Hematopathology and the Society for Hematopathology was held in Bordeaux, France, in September 2008. The panel members reviewed and discussed 145 submitted cases and reached consensus diagnoses. This Workshop summary is focused on the most controversial aspects of gray-zone lymphomas and describes the panel's proposals regarding diagnostic criteria, terminology, and new prognostic and diagnostic parameters.

Original languageEnglish
Pages (from-to)211-36
Number of pages26
JournalJOURNAL OF HEMATOPATHOLOGY
Volume2
Issue number4
DOIs
Publication statusPublished - 22 Dec 2009

Keywords

  • Journal Article

Cite this